Dark Forest Capital Management LP Horizon Therapeutics Public LTD CO Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $499,715 - $582,915	5,187 Added 265.18%	7,143 $734,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $2.47 Million - $2.61 Million	-23,023 Reduced 92.17%	1,956 $213,000
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $1.56 Million - $2.84 Million	24,979 New	24,979 $2.84 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $368,733 - $540,375	-4,644 Reduced 90.6%	482 $38,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $442,988 - $562,886	5,126 New	5,126 $539,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.